You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Mallinckrodt Hospital Products IP Limited v. Altan Pharma Ltd. (D. Del. 2019)

✉ Email this page to a colleague

« Back to Dashboard

Mallinckrodt Hospital Products IP Limited v. Altan Pharma Ltd. (D. Del. 2019)

Docket	⤷ Sign Up	Date Filed	2019-03-22
Court	District Court, D. Delaware	Date Terminated	2019-08-29
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Patents	6,992,218; 9,399,012; 9,610,265; 9,987,238
Link to Docket	External link to docket

Small Molecule Drugs cited in Mallinckrodt Hospital Products IP Limited v. Altan Pharma Ltd.

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Details for Mallinckrodt Hospital Products IP Limited v. Altan Pharma Ltd. (D. Del. 2019)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2019-03-22	1	Complaint	. 6,992,218 (the “’218 patent”) (collectively, the “Patents-in-Suit”). Case 1:19-cv-00552-LPS Document…of U.S. Patent No. 9,399,012 (the “’012 patent”), U.S. Patent No. 9,610,265 (the “’265 patent”), and … U.S. Patent No. 9,987,238 (the “’238 patent”), and is the exclusive sub-licensee of U.S. Patent No. … action for infringement of the Patents-in-Suit pursuant to the Patent Laws of the United States, 35 …the ’218 Patent. Altan’s submission of the Altan NDA constitutes infringement of the Patents-in-Suit	External link to document
2019-08-29	15	Judgment - Consent	.S . Patent Nos. 9,610,265, 9,399,012, 9,987,238, and 6,992,21 8 (the "Plaintiffs Patents"… Plaintiffs Patents was a technical act of infringement of the Plaintiffs Patents under 35 U.S.C…OF PERMANENT INJUNCTION This action for patent infringement has been brought by Plaintiffs, Mallinckrodt…charged Altan with infringement of the Plaintiffs Patents in connection with Altan' s submission… restrained from infringing the Plaintiffs Patents by making, using selling, offering for	External link to document
2019-03-22	4	Patent/Trademark Report to Commissioner of Patents	; 9,610,265 B2; 9,987,238 B2; 6,992,218 B2. (ceg) (Entered: 03/22/2019) 22 March 2019 PACER Document… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,399,012 B2; …2019 29 August 2019 1:19-cv-00552 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.